These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38389126)

  • 21. Dyskerin and telomerase RNA component are sex-differentially associated with outcomes and Sunitinib response in patients with clear cell renal cell carcinoma.
    Yuan H; Qin X; Yang Q; Liu L; Fang Z; Fan Y; Xu D
    Biol Sex Differ; 2023 Jul; 14(1):46. PubMed ID: 37434223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ARRDC1 and ARRDC3 act as tumor suppressors in renal cell carcinoma by facilitating YAP1 degradation.
    Xiao J; Shi Q; Li W; Mu X; Peng J; Li M; Chen M; Huang H; Wang C; Gao K; Fan J
    Am J Cancer Res; 2018; 8(1):132-143. PubMed ID: 29416926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma.
    Yu H; Liu R; Ma B; Li X; Yen HY; Zhou Y; Krasnoperov V; Xia Z; Zhang X; Bove AM; Buscarini M; Parekh D; Gill IS; Liao Q; Tretiakova M; Quinn D; Zhao J; Gill PS
    Br J Cancer; 2015 Aug; 113(4):616-25. PubMed ID: 26180925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CircME1 promotes aerobic glycolysis and sunitinib resistance of clear cell renal cell carcinoma through cis-regulation of ME1.
    Zhang MX; Wang JL; Mo CQ; Mao XP; Feng ZH; Li JY; Lin HS; Song HD; Xu QH; Wang YH; Lu J; Wei JH; Han H; Chen W; Mao HP; Luo JH; Chen ZH
    Oncogene; 2022 Aug; 41(33):3979-3990. PubMed ID: 35798876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival.
    Gustafsson A; Martuszewska D; Johansson M; Ekman C; Hafizi S; Ljungberg B; Dahlbäck B
    Clin Cancer Res; 2009 Jul; 15(14):4742-9. PubMed ID: 19567592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels.
    Fritz HK; Gustafsson A; Ljungberg B; Ceder Y; Axelson H; Dahlbäck B
    PLoS One; 2015; 10(8):e0135991. PubMed ID: 26287733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-96-5p targets PTEN to mediate sunitinib resistance in clear cell renal cell carcinoma.
    Park SE; Kim W; Hong JY; Kang D; Park S; Suh J; You D; Park YY; Suh N; Hwang JJ; Kim CS
    Sci Rep; 2022 Mar; 12(1):3537. PubMed ID: 35241735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and Functional Analysis of Sunitinib-Resistance Induction in Human Renal Cell Carcinoma Cells.
    Rausch M; Rutz A; Allard PM; Delucinge-Vivier C; Docquier M; Dormond O; Wolfender JL; Nowak-Sliwinska P
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma.
    Ruan H; Li S; Bao L; Zhang X
    Oncogene; 2020 Sep; 39(38):6113-6128. PubMed ID: 32814829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EIF3D promotes sunitinib resistance of renal cell carcinoma by interacting with GRP78 and inhibiting its degradation.
    Huang H; Gao Y; Liu A; Yang X; Huang F; Xu L; Danfeng X; Chen L
    EBioMedicine; 2019 Nov; 49():189-201. PubMed ID: 31669222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Sam68 in Sunitinib induced renal cell carcinoma apoptosis.
    Wu Z; Peng Y; Xiong L; Wang J; Li Z; Ning K; Deng M; Wang N; Wei W; Li Z; Dong P; Yu C; Zhou F; Zhang Z
    Cancer Med; 2022 Oct; 11(19):3674-3686. PubMed ID: 35476809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of sunitinib resistance on clear cell renal cell carcinoma therapeutic sensitivity
    Ghosh S; Garige M; Haggerty PR; Norris A; Chou CK; Wu WW; Shen RF; Sourbier C
    Cell Cycle; 2024 Jan; 23(1):43-55. PubMed ID: 38263737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epithelial-mesenchymal transition as a mechanism of resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma.
    Hwang HS; Go H; Park JM; Yoon SY; Lee JL; Jeong SU; Cho YM
    Lab Invest; 2019 May; 99(5):659-670. PubMed ID: 30683903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma.
    Adelaiye-Ogala R; Damayanti NP; Orillion AR; Arisa S; Chintala S; Titus MA; Kao C; Pili R
    Cancer Res; 2018 Jun; 78(11):2886-2896. PubMed ID: 29572225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytoplasmic Expression of AXL Is Associated With High Risk of Postoperative Relapse of Conventional Renal Cell Carcinoma.
    Peterfi L; Bjercke T; Yusenko MV; Kovacs G; Banyai D
    Anticancer Res; 2020 Jun; 40(6):3485-3489. PubMed ID: 32487648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low DAPK1 expression correlates with poor prognosis and sunitinib resistance in clear cell renal cell carcinoma.
    Song Z; Li Z; Han W; Zhu C; Lou N; Li X; Luo G; Peng S; Li G; Zhao Y; Guo Y
    Aging (Albany NY); 2020 Nov; 13(2):1842-1858. PubMed ID: 33201837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AIM2 promotes renal cell carcinoma progression and sunitinib resistance through FOXO3a-ACSL4 axis-regulated ferroptosis.
    Wang Q; Gao S; Shou Y; Jia Y; Wei Z; Liu Y; Shi J; Miao D; Miao Q; Zhao C; Liu C; Yang H; Xu T; Zhang X
    Int J Biol Sci; 2023; 19(4):1266-1283. PubMed ID: 36923928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An In Vitro Analysis of TKI-Based Sequence Therapy in Renal Cell Carcinoma Cell Lines.
    Zaccagnino A; Vynnytska-Myronovska B; Stöckle M; Junker K
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma.
    Shibasaki N; Yamasaki T; Kanno T; Arakaki R; Sakamoto H; Utsunomiya N; Inoue T; Tsuruyama T; Nakamura E; Ogawa O; Kamba T
    PLoS One; 2015; 10(6):e0130980. PubMed ID: 26114873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ZHX2 drives cell growth and migration via activating MEK/ERK signal and induces Sunitinib resistance by regulating the autophagy in clear cell Renal Cell Carcinoma.
    Zhu L; Ding R; Yan H; Zhang J; Lin Z
    Cell Death Dis; 2020 May; 11(5):337. PubMed ID: 32382017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.